Meiji Yasuda Asset Management CO Ltd. Biogen Inc. Transaction History
Meiji Yasuda Asset Management CO Ltd.
- $2.42 Billion
- Q1 2025
A detailed history of Meiji Yasuda Asset Management CO Ltd. transactions in Biogen Inc. stock. As of the latest transaction made, Meiji Yasuda Asset Management CO Ltd. holds 2,163 shares of BIIB stock, worth $293,064. This represents 0.01% of its overall portfolio holdings.
Number of Shares
2,163
Previous 1,960
10.36%
Holding current value
$293,064
Previous $299,000
1.34%
% of portfolio
0.01%
Previous 0.01%
Shares
29 transactions
Others Institutions Holding BIIB
# of Institutions
1,026Shares Held
127MCall Options Held
2.29MPut Options Held
4.26M-
Vanguard Group Inc Valley Forge, PA17MShares$2.31 Billion0.04% of portfolio
-
Primecap Management CO Pasadena, CA15.9MShares$2.16 Billion1.84% of portfolio
-
Black Rock Inc. New York, NY14.5MShares$1.97 Billion0.08% of portfolio
-
State Street Corp Boston, MA7.4MShares$1 Billion0.04% of portfolio
-
Wellington Management Group LLP Boston, MA4.67MShares$633 Million0.13% of portfolio
About BIOGEN INC.
- Ticker BIIB
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 144,000,992
- Market Cap $19.5B
- Description
- Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...